CD8A and neoplasm: have recently demonstrated that CAR- iNKT cells not only mediate direct tumor cytotoxicity but also orchestrate endogenous CD8+ T cell responses against secondary tumor antigens, including ovalbumin (OVA)-derived epitopes, in B16-hCD19 murine models (180).